KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Interest Expenses (2016 - 2025)

Gilead Sciences' Interest Expenses history spans 17 years, with the latest figure at $255.0 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 2.41% year-over-year to $255.0 million; the TTM value through Dec 2025 reached $1.0 billion, up 4.81%, while the annual FY2025 figure was $1.0 billion, 4.81% up from the prior year.
  • Interest Expenses reached $255.0 million in Q4 2025 per GILD's latest filing, roughly flat from $256.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $260.0 million in Q1 2025 to a low of $226.0 million in Q4 2022.
  • Average Interest Expenses over 5 years is $244.2 million, with a median of $245.5 million recorded in 2022.
  • Peak YoY movement for Interest Expenses: fell 10.86% in 2021, then grew 11.5% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $238.0 million in 2021, then dropped by 5.04% to $226.0 million in 2022, then increased by 11.5% to $252.0 million in 2023, then decreased by 1.19% to $249.0 million in 2024, then grew by 2.41% to $255.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Interest Expenses are $255.0 million (Q4 2025), $256.0 million (Q3 2025), and $254.0 million (Q2 2025).